2 results · Page 1 of 1

Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
A Study of TAK-279 in Participants With Moderate-to-Severe Plaque PsoriasisPlaque PsoriasisActive, not recruitingPhase 32026-06-02NCT06550076
A Trial to Evaluate the Efficacy and Safety of Sibeprenlimab Administered Subcutaneously in Participants With Sjögren'sStomatognathic Diseases, Xerostomia, autoimmune disease, dry eye syndrome, eye disorder, immune system disorder, lacrimal apparatus disorder, mouth disorder, salivary gland disorderActive, not recruitingPhase 22026-03-18NCT06928142